| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Phathom Pharmaceuticals, Inc. (PHAT) has 5 insiders with recent SEC Form 4 filings, including 7 buys and 5 sells. PHAT is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 373.3K | $3.99M | - | |
| CFO | 226.7K | $2.42M | - | |
| Other | 90.2K | $964.2K | - | |
| Other | 47.8K | $511.5K | - | |
| Dir | 10.5K | $112.2K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 2, 2020 | Nabulsi Azmi74 | Chief Operating Officer | Sell | 14,500 | $36.83 | $534,026.30 | -1.7% | |
| Apr 1, 2020 | Ra Capital Management, L.P.53 | 10% Owner | Buy | 117,600 | $24.86 | $2,923,641.84 | +3.2% | |
| Mar 31, 2020 | Ra Capital Management, L.P.53 | 10% Owner | Buy | 60,600 | $24.58 | $1,489,263.66 | +0.8% | |
| Jan 5, 2020 | Nabulsi Azmi74 | Chief Operating Officer | Sell | 14,500 | $33.61 | $487,274.67 | -0.4% | |
| Oct 29, 2019 | Cola Michael F | Director | Buy | 9,798 | $19.00 | $186,162.00 | New | |
| Oct 29, 2019 | Edwards Jonathan S. | Director | Buy | 1,052,631 | $19.00 | $19,999,989.00 | +103.7% | |
| Oct 29, 2019 | Frazier Life Sciences Ix, L.P. | 10% Owner | Buy | 1,052,631 | $19.00 | $19,999,989.00 | +16.9% |